Mumbai Worksite Tobacco Control Study
Sponsor: Carelon Research
Listed as NCT01841879, this NA trial focuses on Tobacco Use Cessation and remains completed. Sponsored by Carelon Research, it has been updated 9 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Aug 2023 — Jul 2024 [monthly]
Completed NA
-
Jan 2022 — Aug 2023 [monthly]
Completed NA
-
Jan 2021 — Jan 2022 [monthly]
Completed NA
▶ Show 4 earlier versions
-
Apr 2020 — Jan 2021 [monthly]
Completed NA
-
Jun 2018 — Apr 2020 [monthly]
Completed NA
-
Jun 2017 — Jun 2018 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jan 2017 — Jun 2017 [monthly]
Active Not Recruiting NA
First recorded
Jun 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Carelon Research
- Dana-Farber Cancer Institute
- Harvard School of Public Health (HSPH)
- Healis-Sekhsaria Institute for Public Health
- National Cancer Institute (NCI)
For direct contact, visit the study record on ClinicalTrials.gov .